Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach for Alzheimer's disease. The company targets soluble amyloid-beta oligomers, which are believed to be a key underlying cause of the disease.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.